Fastest-Growing Pharmaceutical Stocks
| Price ($) | Market Cap ($B) | EPS Growth (%) | Revenue Growth (%) | |
| Dynavax Technologies Corp. ( DVAX) | 10.25 | 1.3 | N/A (see company description) | 897.8 |
| Aerie Pharmaceuticals Inc. ( AERI) | 8.26 | 0.4 | N/A (see company description) | 364.6 |
| Verano Holdings Corp. ( VRNOF) | 8.98 | 1.8 | -46.4 | 221.4 |
| # | Name | Price |
|---|---|---|
| 1 | Johnson & Johnson 1JNJ | $173.01 2.09% |
| 2 | Roche 2ROG.SW | $311.77 1.03% |
| 3 | Eli Lilly 3LLY | $297.34 2.21% |
| 4 | Pfizer 4PFE | $48.11 3.40% |
What are the best pharmaceutical stocks?
- Takeda Pharmaceutical Co. ...
- Dynavax Technologies Corp.: Dynavax Technologies is a biopharmaceutical company specializing in developing immunotherapy treatments. ...
- Amphastar Pharmaceuticals Inc.: Amphastar Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and sells generic and injectable, inhalation, and intranasal products. ...
What are the top 10 pharmaceutical companies in the US?
in 2019 by Market Cap
- Johnson & Johnson – Market cap $369.80 billion. Johnson & Johnson is the number one ranked pharmaceutical company in the United States as of July 1, 2019.
- Pfizer – $240.86 billion. Pfizer Inc realized a market cap of $240.86 billion in July of 2019, dropping from its previous market cap of 253.2 billion on December 31, ...
- Merck & Co – $215.88 billion. ...
Why consider investing in pharmaceutical stocks?
- When investing in biotech drug makers, be informed
- Be aware of what you can risk
- Pick companies with promising drug candidate (s), but don’t invest solely on this notion
- Pick drugs that are up for approval within a few years
- Decide if the company can survive until possible approval
- Calculate the average annual sales if the hopeful product succeeds
What are the best stocks to invest in?
When Is the Best Time to Invest In a Roth IRA?
- The Sooner the Better. The amount of tax you pay on Roth contributions depends on how much you earn, so it’s wise to invest in one when you are making ...
- Convert When Income Dips. There is an annual limit to how much you can contribute to a Roth IRA—in 2022 it’s $6,000 ($7,000 if you’re age 50 or older).
- When Federal Income Tax Rates Are Favorable. ...
What is the best pharmaceutical stock to buy?
9 best pharmaceutical stocks to buy for income:AbbVie Inc. (ABBV)Amgen Inc. (AMGN)Cardinal Health Inc. (CAH)Gilead Sciences Inc. (GILD)GlaxoSmithKline PLC (GSK)Novartis AG (NVS)Pfizer Inc. (PFE)Viatris Inc. (VTRS)More items...•
Which pharmaceutical company should I buy a stock in?
Four great pharmaceutical stocksCompany2021 Revenue2021 EarningsAbbVie (NYSE:ABBV)$56.2 billion$11.5 billionBristol Myers Squibb (NYSE:BMY)$46.4 billion$7 billionJohnson & Johnson (NYSE:JNJ)$93.8 billion$20.9 billionPfizer (NYSE:PFE)$81.3 billion$22.4 billion
What is the largest pharmaceutical company in the world 2022?
5 Biggest Pharmaceutical Companies in 2022Johnson & Johnson (NYSE:JNJ) Market cap: US$445.77 billion. ... Roche Holding (OTCQX:RHHBY) Market cap: US$328.57 billion. ... Pfizer (NYSE:PFE) Market cap: US$276.28 billion. ... Novo Nordisk (NYSE:NVO) Market cap: US$238.03 billion. ... Eli Lilly (NYSE:LLY) Market cap: US$237.84 billion.
Is it good time to invest in pharma stocks?
Nonetheless, the Pharma sector is one of the least affected in the COVID-19 situation and strong demand for essential drugs would aid growth for the companies. Pharma companies can be attractive for long-term investors in spite of the volatility.
Is pharmaceutical a good investment?
Despite a reputation for being high risk, pharmaceutical companies can be compelling for long-term investors. With the possibility of patented entry into new areas of treatment, the pharmaceutical industry can present profitable opportunities for those who do their research.
Who is the largest drug manufacturer in the world?
1. Pfizer Inc (US) Pfizer is the world's largest research-based pharmaceutical company.
Which pharma company has the best pipeline?
With 213 products in the 2022 R&D pipeline, Novartis leads the ranking, closely followed by another Swiss company, Roche, and by Japanese Takeda. Among the global top 10 companies based on products in the pipeline, five were from the United States.
Who is the best pharmaceutical company?
5. NovartisCompany RankCompany NameCountry1Johnson & Johnson JNJUSA2Roche RHHBYSwitzerland3Pfizer PFEUSA4Eli Lilly LLYUSA6 more rows•Sep 17, 2021
When do pharmaceutical companies publicize their development?
While pharmaceutical companies have many drugs in various stages of development, most companies only publicize the development of a drug when it advances to clinical testing in humans or is awaiting regulatory approval. Some clinical trials test new drugs, while others test existing drugs for new uses. The best pharmaceutical companies are adept ...
Why is the strength of a drug company important?
While pharmaceutical companies have many drugs in various stages of development, most companies only publicize the development of a drug when it advances to clinical testing in humans or is awaiting regulatory approval.
Why are pharmaceutical companies forced to recall drugs?
Companies can be forced to recall drugs from the market due to safety concerns, and lawsuits against pharma companies are common. As in any industry, pharmaceutical companies face competition from other drugmakers. But competition in this sector can be especially fierce because when patents expire, generic drugmakers are able to produce ...
What drugs did Bristol Myers buy?
The Celgene purchase also brought under Bristol Myers' control the multiple sclerosis and ulcerative colitis drug Zeposia. In early 2021, Bristol Myers won regulatory approval in the U.S. for the cell therapies Abecma and Breyanzi.
How much does it cost to develop a drug?
Image source: Getty Images. The average cost of developing a new drug is $2.6 billion, and the average elapsed time between drug discovery and regulatory approval is 10 years. But the payoff for developing an effective treatment, especially for a common ailment, can be massive.
When will Humira sales decline?
Although sales from Humira are expected to decline in 2023 when AbbVie's patent for the drug expires, the drugmaker’s portfolio also includes several other products with strong sales performances.
Factors That Affect Pharmaceutical Stocks
While the pharmaceutical industry has the potential to yield significant growth in your investment portfolio, it’s important to remember that, as with any other type of stock, not all pharma stocks are created equal. There are a few factors to keep in mind when on the search for the best stocks in the sector:
Best Pharmaceutical Stocks to Buy
Keeping these factors in mind, some of the most impressive stocks in the sector include:
Final Word
If you’re interested in diving into the pharmaceuticals sector, you’re on the right track.
Which pharmaceutical company has 40% of the market share?
Trulicity has 40% of the U.S. market share, and that should rise in coming quarters. Jardiance, which helps lower blood sugar in adults with type 2 diabetes, doubled sales from last year. These and other New Pharmaceuticals accounted for 25% of total revenue and drove 11% volume growth.
What is Merck's second best selling drug?
Also of note was Januvia, which treats diabetes, and increased sales by 7% year over year. Januvia is Merck’s second best-selling drug at $1.4 billion. Though on the small side compared to these top sellers, Merck’s Gardasil, a treatment for HPV, saw revenue increase 24% from the previous year.
What is the largest biotech company in the world?
With a market cap of $126 billion, Amgen is the largest independent biotech company in the world. The company discovers, develops, manufactures and sells medicines to treat serious illnesses in the areas of cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation.
What is Gilead's market cap?
Gilead has a market cap of almost $98 billion .
How much did Symbicort drop in sales?
The company’s respiratory drug Symbicort also faced generic competition that led to a 6% worldwide decline in revenue. Symbicort, which accounts for about 12% of total sales, dropped 28% in the U.S.
What is the market cap of Bristol Myers Squibb?
Today, it is a leading drug maker of cardiovascular and anti-cancer therapeutics. The company has a market cap of more than $90 billion, and generated $21 billion in sales in 2017.
How big is Merck?
With a market cap of nearly $170 billion, Merck & Company is one of the largest healthcare companies in the world. Merck develops, manufactures and markets medicines, vaccines, biologic therapies and animal health products. Merck has nearly 70,000 employees around the world and had sales north of $40 billion in 2017, 57% of which came from outside the U.S.
What is pharmaceutical stock?
Pharmaceutical stocks are the shares of wider healthcare companies that focus on developing, manufacturing and distributing pharmaceutical products, such as drugs, medicines and vaccines. Investing in pharmaceutical stocks is a popular trend in times of political or economic instability. For example, given the Covid-19 crisis, ...
Why do pharmaceutical companies pay dividends?
Paying dividends to investors can help to strengthen loyalty, as well as confidence in success and future payouts.
What are penny stocks?
In recent years, biotech and pharmaceutical penny stocks have become a particular interest to investors as they have often grown into widespread, multinational corporations, including Novavax and Pharma Mar. Penny stocks in the pharma sector have become especially popular throughout the Covid-19 pandemic, as many small businesses raced to develop a coronavirus vaccine, rivalling their larger competitors.
What is Sinopharm Group?
This is throughout mainland China and more recently, on an international level. Sinopharm Group is a primary candidate in the development of the Covid-19 vaccine and professionals are expecting it to be ready for distribution in 2021.
What does share price represent?
Share prices tend to represent the perceived value of a company by investors, and any subsequent profit and loss that may result after opening a trade. In order to value pharma stocks, it's important to analyse company fundamentals : the internal and external factors that may influence the performance of the business.
What is Gilead Pharmaceuticals?
Gilead is a US biopharmaceutical company that focuses on producing antiviral solutions for illnesses that are often overlooked by other healthcare companies. This includes treatment for HIV, liver disease and other inflammatory diseases that are similar to influenza.
Where is GSK headquartered?
GSK is a global pharmaceutical company that is involved in the manufacturing and marketing of vaccines, medicines and other healthcare-related products, headquartered in London. The wide range of operations make it a relatively reliable pharma stock and helps to diversify a trader’s risk portfolio.
What company acquired Five Prime Therapeutics?
In March, the company acquired cancer-focused biotechnology company Five Prime Therapeutics for $1.9 billion to boost its oncology pipeline.
When does Sanofi pay dividends?
The company doesn't have the same recognition as some U.S. giants, and only pays dividends once a year – typically in late April or early May.
Is JNJ a S&P 500 company?
Aside from its unrivaled scale, JNJ is one of only two S&P 500 companies, along with tech giant Microsoft Corp. ( MSFT ), to have a perfect AAA credit rating and boasts $25 billion in cash on its books.
Is there stability in the pharmaceutical industry?
For massive companies that make up the global prescription drug industry, there is a measure of stability in any economic environment as patients pass up discretionary expense first and their medication last. That adds up to steady profits that fuel steady dividends, as evidenced by these nine leading pharma stocks.
Is Bristol Myers a top line drug?
Yet now that the du st has settled, Bristol-Myers looks to be seeing significant top-line and bottom-line benefits. That's on top of an already robust pipeline of drugs that includes blood thinner Eliquis, which saw double-digit growth in the fourth quarter, year over year, to tally more than $2 billion in sales.
Is AstraZeneca stock bad?
AstraZeneca ( AZN) AstraZeneca stock got a bit of bad news in 2021 as some European countries expressed concerns over its coronavirus vaccine and potential blood clots link – but the European Medicines Agency has said the benefits of the company's vaccine outweigh the risks.
Is Abbvie a reliable stock?
AbbVie ( ABBV) AbbVie is as reliable as income investments come, with a track record of 49 consecutive years of dividend increases.
What is the biggest pharmaceutical company?
Starting off this list of the biggest pharmaceutical companies is Johnson & Johnson, a holding company focused on the overarching life science field. Life science companies often specify their focus, but thanks to its massive scale, Johnson & Johnson covers many areas through its subsidiaries.
What is pharmaceutical industry?
As defined by Encyclopedia Britannica, the pharmaceutical sector involves “the discovery, development, and manufacture of drugs and medicines by public and private organizations.”. Pharma companies are developing innovative drugs in areas like immuno-oncology and neurology, as well as novel drugs for a range of rare diseases.
How many scientists does Novartis employ?
For its part, the Alcon division focuses on eyesight and related products. Novartis also employs 6,000 scientists and physicians to further its research and development in the field.
Where is Novartis based?
Novartis is a healthcare company based in Switzerland. It has been in business since 1996 via the merger of Sandoz and Ciba-Geigy; the two companies combined have a history dating back more than 200 years.
Best Pharmaceutical Stocks to Buy in 2022
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is a California-based specialty pharmaceutical company that manufactures and markets inhalation and intranasal products. At the end of 2021, 13 hedge funds held long positions in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), with collective stakes amounting to $28.18 million.
10. Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is a California-based specialty pharmaceutical company that manufactures and markets inhalation and intranasal products. At the end of 2021, 13 hedge funds held long positions in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), with collective stakes amounting to $28.18 million.
Pharmaceutical Stocks: Pfizer ( PFE)
PFE) logo on Pfizer building. Pfizer is an American pharmaceutical corporation." width="300" height="169">Source: Manuel Esteban / Shutterstock.com
Bristol-Myers Squibb ( BMY)
BMY) logo at the top of a cellphone." width="300" height="169">Source: Piotr Swat / Shutterstock.com
AbbVie ( ABBV)
ABBV) website and logo on mobile phone" width="300" height="169">Source: Piotr Swat / Shutterstock.com
Sanofi ( SNY)
SNY) logo on the side of company branch in Germany" width="300" height="169">Source: nitpicker / Shutterstock.com